AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
6min chapter
324: Genentech's cancer pivot, Pfizer's sickle cell withdrawal, and a new schizophrenia drug
The Readout Loud
Withdrawal Woes: A Sickle Cell Drug's Fate
This chapter examines the controversial withdrawal of a sickle cell disease drug by a major pharmaceutical company due to safety concerns raised by regulators. It highlights the implications for future drug approvals and the effectiveness of oversight from the FDA compared to European authorities.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode